Corvus Pharmaceuticals Inc (C17.SG)
| Previous Close | 2.0850 |
| Open | 2.0100 |
| Bid | 1.9760 x 150000 |
| Ask | 2.0500 x 150000 |
| Day's Range | 1.9680 - 2.0950 |
| 52 Week Range | 0.9800 - 3.4600 |
| Volume | |
| Avg. Volume | 41 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
13 Penny Stocks with Insider Buying in 2024
In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks with Insider Buying in 2024. Insider transactions have always drawn market attention as it’s now a well-known fact […]
- Simply Wall St.
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shareholders (or potential shareholders) will be happy to see that the...
- Insider Monkey
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript May 6, 2024 Corvus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon ladies and gentlemen and welcome to the Corvus Pharmaceuticals’ Business Update and Reports First Quarter […]
